3 Marijuana Stocks To Buy In Mid-December?
Marijuana stock investors are looking toward the new year to bring better upward consistency. The way most of the cannabis sector has been trading has shown that volatility can work in the favor of traders. What this means is most times volatile trading has left shareholders taking a loss with a drop in the sector. However with the drastic change in how marijuana stocks trade some have been able to leverage the volatile patterns. In fact, it’s a simple strategy that goes back to the basic saying buy low and sell high. So when there is a volatile decline this can be a good time to find marijuana stocks to buy.
Now recently there have been better moments where the sector has seen an increase in recoveries. But the amount of time a marijuana stock stays in the green is still a short window. Nevertheless, some have become lasered to the point where they have promptly adapted to this new strategy of trading. At one point in time before the Covid pandemic, most marijuana stocks were able to maintain good upward trading. Yet this is not the case as of 2022 but with a new year soon to begin we may see less volatility and better all-around trading. The cannabis stocks to watch below are a few options to keep an eye on this week.
Marijuana Stocks To Watch In The Stock Market
- Red White & Bloom Brands Inc. (OTC:RWBYF)
- Cansortium Inc. (OTC:CNTMF)
- Trulieve Cannabis Corp. ( OTC:TCNNF)
Red White & Bloom Brands Inc.
Red White & Bloom Brands Inc. engages in the cultivation and retail of cannabis products primarily in Michigan, California, and Florida. Plus Oklahoma. The company is headquartered in Vancouver, Canada. On November 29th the company reported its financial results for the three and nine months that ended September 30, 2022. 
2022-Q3 Financial Highlights
- Revenue was $25,543,993, a $14,341,672 or 128% increase when compared to the $11,202,321 revenues reported for the equivalent 2021 quarter.
- Gross profit before fair value adjustments for biological assets was $9,672,086, a $3,809,225 or 65% increase from $5,339,460 in the same quarter of 2021 and a 102% increase from Gross profit before fair value adjustments for biological assets recorded in 2022-Q2.
- Gross profit after fair value adjustments for biological assets was $8,208,447, a $1,344,504 or 20% increase when compared to $6,863,943 in gross profits for the same quarter in 2021 and a 140% increase from Gross profit after fair value adjustments for biological assets recorded in 2022-Q2.
- Operating expenses totaled $9,964,922, a $12,899,475 or 56% decrease when compared to Operating expenses of $22,864,397 for the same period in 2021.
Adjusted EBITDA3 for the quarter was positive $3,311,531.
[Read More] Will These Marijuana Stocks See Better Trading In 2023
Cansortium Inc.
Cansortium Inc. through its subsidiaries produces and sells medical cannabis in the United States. The company engages in cultivation, processing, retail, and distribution activities. In recent news, the company reported its 3rd quarter 2022 financial results. 
Highlights And Key Mentions
- Revenue increased 42% to $22.1 million compared to $15.6 million.
- Florida revenue increased 39% to $18.2 million compared to $13.1 million.
- Adjusted gross profit[1] increased 71% to $16.7 million or 75.5% of revenue, compared to $9.8 million or 62.7% of revenue.
- Adjusted EBITDA increased 140% to a record $11.7 million or 53.1% of revenue, compared to $4.9 million or 31.3% of revenue.
- Cash from operations increased significantly to $5.4 million compared to cash used of $(4.2) million.
[Read More] 2 Marijuana Stocks To Buy Right Now Before 2023?
Trulieve Cannabis Corp.
Trulieve Cannabis Corp. together with its subsidiaries operates as a medical cannabis company. It cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, as well as through home delivery. In recent news, the company opens a new medical cannabis dispensary in Huntington, West Virginia. 
Words From The Company
“We are excited to expand our West Virginia presence to include a location in Huntington, and we look forward to serving patients in the surrounding area,” said Trulieve CEO Kim Rivers. “Trulieve is committed to providing the best quality services and products for the state’s registered medical cannabis patients while strengthening community connections in this developing market.”
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
